Amalgamated Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
6,757
+598
| +10% | +$21.8K | ﹤0.01% | 1499 |
|
|
2025
Q1 | $223K | Buy |
6,159
+187
| +3% | +$6.77K | ﹤0.01% | 1506 |
|
|
2024
Q4 | $251K | Buy |
5,972
+76
| +1% | +$3.19K | ﹤0.01% | 1520 |
|
|
2024
Q3 | $328K | Hold |
5,896
| – | – | ﹤0.01% | 1448 |
|
|
2024
Q2 | $242K | Buy |
5,896
+696
| +13% | +$28.6K | ﹤0.01% | 1529 |
|
|
2024
Q1 | $243K | Sell |
5,200
-10,516
| -67% | -$491K | ﹤0.01% | 1543 |
|
|
2023
Q4 | $752K | Buy |
15,716
+1,427
| +10% | +$68.3K | 0.01% | 1270 |
|
|
2023
Q3 | $509K | Sell |
14,289
-398
| -3% | -$14.2K | ﹤0.01% | 1399 |
|
|
2023
Q2 | $678K | Buy |
14,687
+1,350
| +10% | +$62.3K | 0.01% | 1289 |
|
|
2023
Q1 | $535K | Sell |
13,337
-1,336
| -9% | -$53.6K | ﹤0.01% | 1391 |
|
|
2022
Q4 | $680K | Buy |
14,673
+251
| +2% | +$11.6K | 0.01% | 1317 |
|
|
2022
Q3 | $597K | Buy |
14,422
+134
| +0.9% | +$5.55K | 0.01% | 1348 |
|
|
2022
Q2 | $852K | Buy |
14,288
+117
| +0.8% | +$6.98K | 0.01% | 1206 |
|
|
2022
Q1 | $1.03M | Buy |
14,171
+968
| +7% | +$70.3K | 0.01% | 1186 |
|
|
2021
Q4 | $1.11M | Buy |
13,203
+1,524
| +13% | +$128K | 0.01% | 1177 |
|
|
2021
Q3 | $1.05M | Sell |
11,679
-688
| -6% | -$62K | 0.01% | 1219 |
|
|
2021
Q2 | $1.18M | Buy |
12,367
+3,318
| +37% | +$316K | 0.01% | 1211 |
|
|
2021
Q1 | $1.03M | Sell |
9,049
-724
| -7% | -$82.4K | 0.04% | 542 |
|
|
2020
Q4 | $1.35M | Buy |
9,773
+829
| +9% | +$115K | 0.05% | 382 |
|
|
2020
Q3 | $735K | Sell |
8,944
-128
| -1% | -$10.5K | 0.03% | 626 |
|
|
2020
Q2 | $710K | Sell |
9,072
-909
| -9% | -$71.1K | 0.03% | 612 |
|
|
2020
Q1 | $443K | Sell |
9,981
-660
| -6% | -$29.3K | 0.01% | 964 |
|
|
2019
Q4 | $454K | Buy |
10,641
+970
| +10% | +$41.4K | 0.01% | 1171 |
|
|
2019
Q3 | $414K | Sell |
9,671
-119
| -1% | -$5.09K | 0.01% | 1141 |
|
|
2019
Q2 | $622K | Buy |
9,790
+1,761
| +22% | +$112K | 0.01% | 964 |
|
|
2019
Q1 | $557K | Buy |
8,029
+1,142
| +17% | +$79.2K | 0.01% | 952 |
|
|
2018
Q4 | $299K | Buy |
6,887
+4,142
| +151% | +$180K | 0.01% | 1176 |
|
|
2018
Q3 | $210K | Sell |
2,745
-4,431
| -62% | -$339K | 0.01% | 1305 |
|
|
2018
Q2 | $552K | Buy |
7,176
+1,236
| +21% | +$95.1K | 0.01% | 974 |
|
|
2018
Q1 | $303K | Buy |
5,940
+553
| +10% | +$28.2K | 0.01% | 1205 |
|
|
2017
Q4 | $250K | Buy |
5,387
+351
| +7% | +$16.3K | 0.01% | 1362 |
|
|
2017
Q3 | $268K | Buy |
5,036
+56
| +1% | +$2.98K | 0.01% | 1290 |
|
|
2017
Q2 | $309K | Buy |
4,980
+352
| +8% | +$21.8K | 0.01% | 1183 |
|
|
2017
Q1 | $314K | Buy |
4,628
+202
| +5% | +$13.7K | 0.02% | 1102 |
|
|
2016
Q4 | $311K | Buy |
4,426
+616
| +16% | +$43.3K | 0.01% | 1114 |
|
|
2016
Q3 | $270K | Buy |
3,810
+5
| +0.1% | +$354 | 0.02% | 1074 |
|
|
2016
Q2 | $260K | Sell |
3,805
-242
| -6% | -$16.5K | 0.02% | 1102 |
|
|
2016
Q1 | $256K | Buy |
4,047
+354
| +10% | +$22.4K | 0.02% | 979 |
|
|
2015
Q4 | $414K | Sell |
3,693
-334
| -8% | -$37.4K | 0.05% | 552 |
|
|
2015
Q3 | $388K | Buy |
4,027
+313
| +8% | +$30.2K | 0.04% | 690 |
|
|
2015
Q2 | $380K | Buy |
+3,714
| New | +$380K | 0.04% | 774 |
|